logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Countdown to Breaking 7? Light of dawn in China-US trade negotiations, Goldman Sachs bullish on the future of the Renminbi.

date
12/05/2025
According to the Securities Times app, with progress in the US-China trade negotiations, Goldman Sachs has raised its forecast for the Renminbi to US dollar exchange rate to 7.0 in the next 12 months.
Latest
now
Brazilian President Lula: In the face of the resurgence of protectionist barriers, we are committed to reducing industry barriers and hope for more integration.
now
Rongchang Biotech (09995): Antibody-drug conjugate RC278 receives notice of drug clinical trial application acceptance.
1 m ago
Rainbow Technology: The asking price for the transfer is 38.59 yuan/share.
1 m ago
Tianyi Medical (301097.SZ) plans to distribute 5 yuan for every 10 shares in 2024. The ex-right and ex-dividend date is May 16th.
1 m ago
Rongchang Biological (09995): The phase III clinical study of vedolizumab monotherapy for first-line treatment of HER2-expressing urothelial carcinoma has reached the main study endpoint.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.